Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.
2.

Ectopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formation.

Martinez-Ruiz GU, Victoria-Acosta G, Vazquez-Santillan KI, Jimenez-Hernandez L, Muñoz-Galindo L, Ceballos-Cancino G, Maldonado V, Melendez-Zajgla J.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5515-26. eCollection 2014 Aug 15.

3.

Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.

Bechill J, Muller WJ.

Mol Immunol. 2014 Nov;62(1):96-103. doi: 10.1016/j.molimm.2014.06.013. Epub 2014 Jun 28.

4.

IL-8 and global gene expression analysis define a key role of ATP in renal epithelial cell responses induced by uropathogenic bacteria.

Kruse R, Demirel I, Säve S, Persson K.

Purinergic Signal. 2014 Sep;10(3):499-508. doi: 10.1007/s11302-014-9414-7. Epub 2014 May 10.

5.

TRAF molecules in cell signaling and in human diseases.

Xie P.

J Mol Signal. 2013 Jun 13;8(1):7. doi: 10.1186/1750-2187-8-7.

6.

Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.

Hu X, Zimmerman MA, Bardhan K, Yang D, Waller JL, Liles GB, Lee JR, Pollock R, Lev D, Ware CF, Garber E, Bailly V, Browning JL, Liu K.

Carcinogenesis. 2013 May;34(5):1105-14. doi: 10.1093/carcin/bgt014. Epub 2013 Jan 24. No abstract available.

7.

Association between genetic variations in tumor necrosis factor receptor genes and survival of patients with T-cell lymphoma.

Zhai K, Chang J, Wu C, Lu N, Huang LM, Zhang TW, Yu DK, Tan W, Lin DX.

Chin J Cancer. 2012 Jul;31(7):335-41. doi: 10.5732/cjc.011.10448. Epub 2012 May 24.

8.

Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis.

Pérez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, Vallabhapurapu S, Bravo J, Warnatz K, Chaix Y, Cascarrigny F, Lebon P, Rozenberg F, Karin M, Tardieu M, Al-Muhsen S, Jouanguy E, Zhang SY, Abel L, Casanova JL.

Immunity. 2010 Sep 24;33(3):400-11. doi: 10.1016/j.immuni.2010.08.014. Epub 2010 Sep 9.

9.

HOIL-1L interacting protein (HOIP) as an NF-kappaB regulating component of the CD40 signaling complex.

Hostager BS, Fox DK, Whitten D, Wilkerson CG, Eipper BA, Francone VP, Rothman PB, Colgan JD.

PLoS One. 2010 Jun 30;5(6):e11380. doi: 10.1371/journal.pone.0011380.

10.

TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.

Bista P, Zeng W, Ryan S, Bailly V, Browning JL, Lukashev ME.

J Biol Chem. 2010 Apr 23;285(17):12971-8. doi: 10.1074/jbc.M109.076091. Epub 2010 Feb 25.

11.

A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.

Dai Y, Liu M, Tang W, Li Y, Lian J, Lawrence TS, Xu L.

BMC Cancer. 2009 Nov 6;9:392. doi: 10.1186/1471-2407-9-392.

12.

Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation.

Csomos RA, Wright CW, Galbán S, Oetjen KA, Duckett CS.

Biochem J. 2009 Apr 28;420(1):83-91. doi: 10.1042/BJ20082140.

13.

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL.

Cancer Cell. 2007 Aug;12(2):131-44.

15.

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.

Arellano-Llamas A, Garcia FJ, Perez D, Cantu D, Espinosa M, De la Garza JG, Maldonado V, Melendez-Zajgla J.

BMC Cancer. 2006 Oct 26;6:256.

16.

Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis.

Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, Chen YH, Wang CR, Schulick R, Flies AS, Flies DB, Zhu G, Xu Y, Pardoll DM, Chen L, Tamada K.

J Clin Invest. 2006 Apr;116(4):1045-51. Epub 2006 Mar 23.

17.

NF-kappaB activation in melanoma.

Ueda Y, Richmond A.

Pigment Cell Res. 2006 Apr;19(2):112-24. Review.

18.

TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.

Kim YS, Nedospasov SA, Liu ZG.

Mol Cell Biol. 2005 Mar;25(6):2130-7.

Supplemental Content

Support Center